Please try another search
Hubei Biocause Pharmaceutical Co.,Ltd. is a China-based company principally engaged in insurance business, such as life insurance, health insurance and casualty insurance. The Company is also involved in pharmaceutical business and chemical business. The Company’s products include polypropylene and Ibuprofen. The Company distributes its products in domestic market and to overseas markets, with Central China and South China as its main markets.
Name | Age | Since | Title |
---|---|---|---|
Yi Qian Liu | 59 | 2015 | Chairman of the Board of Directors |
Shi Yan Wu | 59 | 2012 | Chairman of the Supervisory Board |
Jun Lu | 50 | 2020 | Employee Supervisor |
Jianqiang Shen | 50 | 2018 | Supervisory Board Member |
Dali Chen | 60 | 2020 | CFO & Director |
Xiang Xu | 52 | 2018 | Independent Director |
Fei Long | 43 | 2020 | Secretary of the Board & Non-Independent Director |
Wenxia Zhou | 50 | 2020 | Vice Chairman & GM |
Wan Fu Liu | 58 | 2018 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review